These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16390880)

  • 41. Acute tryptophan depletion: a method of studying antidepressant action.
    Miller HL; Delgado PL; Salomon RM; Licinio J; Barr LC; Charney DS
    J Clin Psychiatry; 1992 Oct; 53 Suppl():28-35. PubMed ID: 1429482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review: Serotonin by stress interaction: a susceptibility factor for the development of depression?
    Firk C; Markus CR
    J Psychopharmacol; 2007 Jul; 21(5):538-44. PubMed ID: 17446201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet serotonin markers and depressive symptomatology.
    Sheline YI; Bardgett ME; Jackson JL; Newcomer JW; Csernansky JG
    Biol Psychiatry; 1995 Apr; 37(7):442-7. PubMed ID: 7786957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The serotonin system and aggressive personality disorder.
    Siever L; Trestman RL
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():33-9. PubMed ID: 8201245
    [No Abstract]   [Full Text] [Related]  

  • 45. Flesinoxan challenge suggests that chronic treatment with paroxetine in rats does not desensitize receptors controlling 5-HT synthesis.
    Skelin I; Yamane F; Diksic M
    Neurochem Int; 2008 Dec; 53(6-8):236-43. PubMed ID: 18786747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J; Peroutka SJ
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of 5-HT1A and 5-HT7 receptors in Caco-2 cells and their role in the regulation of serotonin transporter activity.
    Iceta R; Mesonero JE; Aramayona JJ; Alcalde AI
    J Physiol Pharmacol; 2009 Mar; 60(1):157-64. PubMed ID: 19439818
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acceleration of serotonin transporter transport-associated current by 3,4-methylenedioxymethamphetamine (MDMA) under acidic conditions.
    Yamauchi Y; Izumi T; Unemura K; Uenishi Y; Nakagawa T; Kaneko S
    Neurosci Lett; 2007 Nov; 428(2-3):72-6. PubMed ID: 17949903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serotonergic dysfunction and aggression control.
    Van Praag HM
    Psychol Med; 1991 Feb; 21(1):15-9. PubMed ID: 2047491
    [No Abstract]   [Full Text] [Related]  

  • 50. Structural plasticity: cause, result, or correlate of depression.
    Gage FH
    Biol Psychiatry; 2000 Oct; 48(8):713-4. PubMed ID: 11063967
    [No Abstract]   [Full Text] [Related]  

  • 51. The role of dopamine in the pathophysiology of depression.
    Dunlop BW; Nemeroff CB
    Arch Gen Psychiatry; 2007 Mar; 64(3):327-37. PubMed ID: 17339521
    [No Abstract]   [Full Text] [Related]  

  • 52. Vulnerability to lasting anxiogenic effects of brief exposure to predator stimuli: sex, serotonin and other factors-relevance to PTSD.
    Adamec R; Holmes A; Blundell J
    Neurosci Biobehav Rev; 2008 Sep; 32(7):1287-92. PubMed ID: 18550167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Chronic fatigue syndrome and neurotransmitters].
    Miwa S; Takikawa O
    Nihon Rinsho; 2007 Jun; 65(6):1005-10. PubMed ID: 17561689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuroendocrine evidence for age-related decline in central serotonergic function.
    Lerer B; Gelfin Y; Shapira B
    Neuropsychopharmacology; 1999 Aug; 21(2):321-2. PubMed ID: 10432480
    [No Abstract]   [Full Text] [Related]  

  • 55. Deuterium content of water increases depression susceptibility: the potential role of a serotonin-related mechanism.
    Strekalova T; Evans M; Chernopiatko A; Couch Y; Costa-Nunes J; Cespuglio R; Chesson L; Vignisse J; Steinbusch HW; Anthony DC; Pomytkin I; Lesch KP
    Behav Brain Res; 2015 Jan; 277():237-44. PubMed ID: 25092571
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluoxetine mechanism of action.
    Fuller RW; Beasley CM
    J Am Acad Child Adolesc Psychiatry; 1991 Sep; 30(5):849-50. PubMed ID: 1938808
    [No Abstract]   [Full Text] [Related]  

  • 57. Developmental risk I: depression and the developing brain.
    Weir JM; Zakama A; Rao U
    Child Adolesc Psychiatr Clin N Am; 2012 Apr; 21(2):237-59, vii. PubMed ID: 22537725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serotonergic mechanisms in psychiatric disorders: new research tools, new ideas.
    Benkelfat C
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():53-6. PubMed ID: 8201247
    [No Abstract]   [Full Text] [Related]  

  • 59. 5-HT2 neurotransmission in major depression.
    Ramasubbu R
    Br J Psychiatry; 1998 Jun; 172():541. PubMed ID: 9829001
    [No Abstract]   [Full Text] [Related]  

  • 60. Brain Serotonin, Carbohydrate-craving, obesity and depression.
    Wurtman RJ; Wurtman JJ
    Adv Exp Med Biol; 1996; 398():35-41. PubMed ID: 9045545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.